We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTK
2076
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $230K | ﹤0.01% |
32,626
| – | – |
|
|
AFMD
2077
DELISTED
Affimed
AFMD
| $226K | ﹤0.01% |
2,860
-3,749
| -57% | -$243K |
|
2078
HEICO Corp
HEI
$50.9B
| $226K | ﹤0.01% |
1,811
-3,944
| -69% | -$507K |
|
2079
Select Water Solutions
WTTR
$2.69B
| $226K | ﹤0.01% |
+45,436
| New | +$264K |
|
|
ZYXI
2080
DELISTED
Zynex
ZYXI
| $226K | ﹤0.01% |
16,304
-13,866
| -46% | -$212K |
|
2081
Wave Life Sciences
WVE
$1.2B
| $225K | ﹤0.01% |
40,058
-18,458
| -32% | -$177K |
|
2082
Apple Hospitality REIT
APLE
$3.71B
| $224K | ﹤0.01% |
15,381
-20,206
| -57% | -$281K |
|
2083
Cogent Communications
CCOI
$528M
| $224K | ﹤0.01% |
3,261
-17,599
| -84% | -$1.08M |
|
2084
LeMaitre Vascular
LMAT
$1.86B
| $224K | ﹤0.01% |
4,588
-1,068
| -19% | -$50.1K |
|
|
MNRL
2085
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $224K | ﹤0.01% |
15,291
+1,330
| +10% | +$19.3K |
|
2086
Acadia Pharmaceuticals
ACAD
$5.06B
| $223K | ﹤0.01% |
8,661
-2,810
| -24% | -$124K |
|
2087
Intellicheck
IDN
$76.1M
| $222K | ﹤0.01% |
26,448
+6,924
| +35% | +$81.1K |
|
2088
BrightView Holdings
BV
$1.05B
| $221K | ﹤0.01% |
13,120
-1,931
| -13% | -$30.9K |
|
2089
Nicolet Bankshares
NIC
$3.63B
| $221K | ﹤0.01% |
+2,653
| New | +$202K |
|
2090
Ducommun
DCO
$2.94B
| $220K | ﹤0.01% |
3,669
-575
| -14% | -$32.1K |
|
|
IGMS
2091
DELISTED
IGM Biosciences
IGMS
| $220K | ﹤0.01% |
+2,875
| New | +$262K |
|
2092
AXIS Capital
AXS
$7.43B
| $219K | ﹤0.01% |
+4,411
| New | +$221K |
|
2093
Helix Energy Solutions
HLX
$1.47B
| $219K | ﹤0.01% |
+43,351
| New | +$216K |
|
|
TVRD
2094
Tvardi Therapeutics
TVRD
$22M
| $218K | ﹤0.01% |
+278
| New | +$190K |
|
2095
Eagle Bancorp
EGBN
$843M
| $217K | ﹤0.01% |
+4,074
| New | +$198K |
|
2096
PTC Therapeutics
PTCT
$6.23B
| $217K | ﹤0.01% |
4,583
-6,172
| -57% | -$367K |
|
2097
Nabors Industries
NBR
$1.33B
| $216K | ﹤0.01% |
+2,310
| New | +$206K |
|
|
FRTA
2098
DELISTED
Forterra, Inc
FRTA
| $216K | ﹤0.01% |
9,284
-99,729
| -91% | -$2.15M |
|
|
GOLD
2099
Gold.com Inc
GOLD
$1.26B
| $214K | ﹤0.01% |
+11,888
| New | +$186K |
|
2100
Rimini Street
RMNI
$458M
| $212K | ﹤0.01% |
+23,645
| New | +$183K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.